N-((1R,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl)octanamide
In Stock•Starting at $47 for 5 mg•Purity ≥ 98%
| CAS No. | 491833-29-5 |
|---|---|
| MDL No. | MFCD19443735 |
| MF | C23H36N2O4 |
| MW | 404.50 |
| InChI Key | FJZZPCZKBUKGGU-AUSIDOKSSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 5 mg | 98% | $47 | In Stock | |
| 10 mg | 98% | $69 | In Stock | |
| 25 mg | 98% | $82 | In Stock | |
| 50 mg | 98% | $97 | In Stock |
Product Information
Eliglustat is a carboxamide formed by the formal condensation of the carboxy group of octanoic acid with the primary amino group of (1R,2R)-2-amino-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(pyrrolidin-1-yl)propan-1-ol. It is a ceramide glucosyltransferase inhibitor, used as its tartrate salt in the treatment of Gaucher's disease. It acts as an EC 2.4.1.80 inhibitor. Eliglustat is a benzodioxine, N-alkylpyrrolidine, secondary alcohol, and carboxamide. It is the conjugate base of eliglustat(1+).
| CAS No. | 491833-29-5 |
|---|---|
| Product Name | N-((1R,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl)octanamide |
Biological Targets
UGCG
Associated Conditions
hematopoietic and lymphoid cell neoplasm·Gaucher disease·Gaucher disease type 3·Gaucher disease type 1
* The information provided here is compiled from public sources and is for reference only.